Since its inception, the INC has made significant strides in neonatal health. Some notable achievements include:
Development of Standardized Clinical Trial Protocols: Ensuring that trials are designed to meet the specific needs of neonates. Identification of Biomarkers: Discovering biomarkers that can predict and monitor neonatal diseases. Creation of Regulatory Guidelines: Collaborating with regulatory agencies to create guidelines that facilitate the approval of neonatal therapies.
